Vnitr Lek 2012, 58(3):237-240

Recommendations of care for patients with prediabetes

T. Pelikánová

Received: March 5, 2012; Published: March 1, 2012  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Pelikánová T. Recommendations of care for patients with prediabetes. Vnitr Lek. 2012;58(3):237-240.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Abdul-Ghani MA, DeFronzo RA. Pathophysiology of prediabetes. Curr Diab Rep 2009; 9: 193-199. Go to original source... Go to PubMed...
    2. American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes Care 2012; 35: S11-S63. Go to original source... Go to PubMed...
    3. Borai A, Livingstone C, Abdelaal F et al. The relationship between glycosylated haemoglobin (HbA1c) and measures of insulin resistance across a range of glucose tolerance. Scand J Clin Lab Invest 2011; 71: 168-172. Go to original source... Go to PubMed...
    4. Barr EL, Zimmet PZ, Welborn TA et al. Risk of cardiovascular and all-cause mortality in individuals with diabetes mellitus, impaired fasting glucose and impaired glucose tolerance: The Australian Diabetes, Obesity and Lifestyle Study (AusDiab). Circulation 2007; 116: 151-157. Go to original source... Go to PubMed...
    5. Brambilla P, La Valle E, Falbo R et al. Normal Fasting Plasma Glucose and Risk of Type 2 diabetes. Diabetes Care 2011; 34: 1372-1374. Go to original source... Go to PubMed...
    6. Buysschaert M, Bergman M. Definition of prediabetes. Med Clin North Am 2011; 95: 289-297. Go to original source... Go to PubMed...
    7. Colagiuri S. Epidemiology of prediabetes. Med Clin North Am 2011; 95: 299-307. Go to original source... Go to PubMed...
    8. Faerch K, Vaag A, Holst JJ et al. Impaired fasting glycaemia vs impaired glucose tolerance: similar impairment of pancreatic alpha and beta cell function but differential roles of incretin hormones and insulin action. Diabetologia 2008; 51: 853-861. Go to original source... Go to PubMed...
    9. Faerch K, Vaag A, Holst JJ et al. Natural history of insulin sensitivity and insulin secretion in the progression from normal glucose tolerance to impaired fasting glycemia and impaired glucose tolerance: the Inter99 study. Diabetes Care 2009; 32: 439-444. Go to original source... Go to PubMed...
    10. Garber AJ. Hypertension and lipid management in prediabetic states. J Clin Hypertens 2001; 13: 270-224. Go to original source... Go to PubMed...
    11. Heianza Y, Hara S, Arase Y et al. HbA1c 5.7-6.4% and impaired fasting plasma glucose for diagnosis of prediabetes and risk of progression to diabetes in Japan (TOPICS 3): a longitudinal cohort study. Lancet 2011; 378: 147-155. Go to original source... Go to PubMed...
    12. James C, Bullard KM, Rolka DB et al. Implications of Alternative Definitions of Prediabetes for Prevalence in U.S. Adults. Diabetes Care 2011; 34: 387-391. Go to original source... Go to PubMed...
    13. Lilly M, Godwin M. Treating prediabetes with metformin: systematic review and meta-analysis. Can Fam Physician 2009; 55: 363-369. Go to PubMed...
    14. Lipska KJ, Bailey CJ, Inzucchi SE. Use of metformin in the setting of mild-to-moderate renal insufficiency. Diabetes Care 2011; 34: 1431-1437. Go to original source... Go to PubMed...
    15. Priya M, Mohan Anjana R, Pradeepa R et al. Comparison of capillary whole blood versus venous plasma glucose estimations in screening for diabetes mellitus in epidemiological studies in developing countries. Diabetes Technol Ther 2011; 13: 586-591. Go to original source... Go to PubMed...
    16. Ratner RE, Sathasivam A. Treatment recommendations for prediabetes. Med Clin North Am 2011; 95: 385-395. Go to original source... Go to PubMed...
    17. Tankova T, Chakarova N, Atanassova I et al. Evaluation of the Finnish Diabetes Risk Score as a screening tool for impaired fasting glucose, impaired glucose tolerance and undetected diabetes. Diabetes Res Clin Pract 2011; 92: 46-52. Go to original source... Go to PubMed...
    18. Widén EI, Eriksson JG, Groop LC. Metformin normalizes nonoxidative glucose metabolism in insulin-resistant normoglycemic first-degree relatives of patients with NIDDM. Diabetes 1992; 41: 354-358. Go to original source... Go to PubMed...

    Return to the content


    Vnitřní lékařství

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.